Wave Life Sciences price target raised to $50 from $47 at Clear Street [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
the rights to WVE-006 for alpha1-antitrypsin deficiency. The firm views the news as an “overall positive.” The muted stock reaction today is due to the outsized importance of WVE-007 in Wave Life's valuation overshadowing its alpha-1 antitrypsin deficiency program, the analyst tells investors in a research note. Clear Street still believes in the program despite GSK's decision. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now See the top stocks recommended by analysts Read More on WVE: Disclaimer & Disclosure Report an Issue Wave Life Sciences Regains WVE-006 Rights, Plans Accelerated Path Wave Life Sciences regains full rights to WVE-006 3 ‘Strong Buy' Biotech Stocks to Buy Today, 1/13/2026, According to Top Analysts W
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) was given a new $43.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin DeficiencyGlobeNewswire
WVE
Earnings
- 11/10/25 - Miss
WVE
Sec Filings
- 2/5/26 - Form SCHEDULE
- 2/2/26 - Form 8-K
- 1/12/26 - Form 8-K
- WVE's page on the SEC website